Dr. Lal Pathlabs was incorporated as ‘Dr. Lal PathLabs Private Limited’, a private limited company under the Companies Act, 1956, with a certificate of incorporation issued by the Registrar of Companies, National Capital Territory of Delhi and Haryana (RoC) on February 14, 1995 at Delhi. Subsequently, the name of the company was changed to ‘Dr. Lal PathLabs Limited’ upon conversion of the company into a public limited company pursuant to a special resolution of the shareholders of the company dated August 7, 2015 and a fresh certificate of incorporation was issued by the RoC on August 19, 2015. The company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of bio-chemistry, hematology, histopathology, microbiology, electrophoresis, immunochemistry, immunology, virology, cytology, and other pathological and radiological investigations.

The company is well known and widely regarded for consistently introducing pioneer tests and technologies in Indian Diagnostics Market. The company has launched multiple “Center of Excellence” in recent times focusing on various specialities such as Genevolve (Genetic Testing), L-ACE(Autoimmunity), L-CoRD (Reproductive Diagnosis) & L-CID (Infectious Diseases) defining the steps towards Medical Excellence. The company has expanded its test offering which include basic preventive health packages “SwasthFit” to most advanced investigations such as Comprehensive Genomic Profile, Myeloid testing for Haematological Malignancies & Amyloid Typing Solutions. The company is actively working to introduce the Artificial Intelligence based algorithm in multiple diagnostics areas such as Histopath & Haematology to improve the efficiency, accuracy and reproducibility of results.

Business area of the company

The company is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions. Its customers include individual patients, hospitals and other healthcare providers and corporate customers.

Popular tests of the company 

• Pregnancy Test
• Full Body Checkups
• Heart Test
• Kidney Test
• Liver Test
• CBC Test
• Cholesterol Test
• HbA1c Test
• Hepatitis B Test
• Kidney Function Test
• Liver Function Test
• Sugar Test
• Thyroid Test
• Typhoid Test
• Uric Acid Test
• Vitamin B12 Test
• Vitamin D Test
• Allergy Test
• Arthritis Test
• Cancer Test
• Bone And Joint
• Dengue Test
• Diabetes Test
• Rheumatoid Test
• Tuberculosis Test
• Infertility Test
• Diabetes Care
• Anemia Test
• GastroIntestinal
• Autoimmune Disorders
• Fever Test

Awards and accreditations

• 2001: Received the ISO 9001:2008 certification for the quality management system for performance of routine and advanced diagnostic pathology testing services, including in clinical trials.
• 2002: Fully accredited by the College of American Pathologists’ Laboratory Accreditation Program.
• 2008: Awarded the CNBC TV18 Emerging India Award 2008 by ICICI Bank Business Banking in the pharmaceuticals and chemicals category.
• 2010: Franchisor of the Year in healthcare, at the Franchise Plus Awards.
• 2010: Honourable mention in the healthcare category at the Milagrow Trailblazers Brand Innovator Awards.
• 2012: Diagnostic Service Provider Company of the Year, by Frost & Sullivan at the 4th Annual India Healthcare Excellence Awards.
• 2012: Named a Computerworld Honours Laureate by the Computerworld Honours Program for innovative use of information technology to conduct research, develop new diagnostic methods and services and improve quality and access of patients to healthcare.
• 2013: Best Diagnostic Company in India at the VC Circle Healthcare Summit.
• 2014: Received the ISO 27001:2013 certification for the information management system for providing data center services and supporting functions.
• 2014: Received an NABL certificate of accreditation under standard ISO 15189:2012 for “Medical Laboratories - Requirements for Quality and Competence” for medical testing, for National Reference Laboratory.
• 2015: Data Quest Technology Award for Excellence in the implementation and use of technology for business benefits in the ‘Cloud’ category.
• 2015: Received the certificate of affiliation from the Healthcare Sector Skill Council for role as medical laboratory technician in relation to institute at Gurgaon, Haryana, India.

Major events and milestones

• 1949: Founded by Dr. Major S. K. Lal.
• 1995: Company incorporated as Dr Lal PathLabs Private Ltd.
• 2000: Dr Lal Path Labs at Hanuman Road, Delhi received NABL Accreditation.
• 2001: Dr Lal Path Labs at Hanuman Road, Delhi received ISO 9001:2000 certification.
• 2002: Dr Lal Path Labs at Hanuman Road, Delhi received International Accreditation from CAP.
• 2005: onwards Investment by WestBridge Capital.
• 2008: Acquisition of Paliwal Medicare Private Limited and Paliwal Diagnostics Private Limited.
• 2010: National Reference Lab set up in Delhi.
• 2015: Successful IPO listing in Dec 2015.
• 2017: Introduction of Next Generation Sequencing (NGS).
• 2017: Launch of Kolkata Reference Lab.
• 2017: Inauguration of first international lab in Nepal.
• 2018: Inauguration of second international lab in Bangladesh.
• 2019: Launch of Genevolve centre of excellence for Genetic testing.
• 2020: First COVID RT-PCR testing network in private sector in India.
• 2021: Acquisition of Suburban Diagnostics in Mumbai.
• 2022: Launch of Bangalore Reference Lab.
• 2023: Launch of Mumbai Reference Lab.
• 2025: Dr. Lal PathLabs expands genomics capabilities with Illumina's NovaSeq X Series.
• 2025: Dr. Lal PathLabs launches test for Amyloidosis disease.
• 2025: Dr. Lal Pathlabs pioneers AI integration in cancer diagnosis in India.
• 2025: Dr. Lal PathLabs launches India’s first dedicated Complement Testing Laboratory.
• 2026: Dr. Lal PathLabs sets new standard in preventive healthcare with launch of Sovaaka.